Xanadu Quantum Technologies announced a major algorithmic breakthrough in Quantum Read-Only Memory that halves the Toffoli gate operations required for QROM workloads. The company says this advance ...
Ciena's GeoMesh Extreme with WaveLogic 6 Extreme optical technology has gone live on the Matrix Cable System. Matrix NAP Info is among the first operators in Southeast Asia to commercially activate ...
Hosted on MSN
This 6.5%-yielding dividend payer is sitting on a breakthrough investors haven’t priced in
Pfizer (PFE) offers a rare combination of a 6.5% dividend yield with a promising pipeline of oncology treatments and a new Lyme disease vaccine, trading at 9.1x forward P/E despite being 55% below its ...
Editor’s Note: Yesterday, we shared Marc Chaikin’s thoughts on how investors can fall behind when markets change and old strategies stop working. Today, he’s taking that idea a step further. Marc is ...
Oil prices climbed on Friday as investors doubted the prospects of a breakthrough in U.S.-Iran peace talks, with the two ...
Opportunities to invest in commercial nuclear fusion are limited for now, but these companies stand to benefit from their ...
SAN DIEGO & CANBERRA, Australia-- (BUSINESS WIRE)--Liquid Instruments, a leading innovator of reconfigurable test instrumentation, today announced that it has secured a new round of funding totaling ...
With so much momentum across the company's top line, investors should be curious about what's fueling this growth. Thankfully, the detailed notes in IonQ's latest 10-Q filing can help uncover the ...
Pfizer (PFE) offers a rare combination of a 6.5% dividend yield with a promising pipeline of oncology treatments and a new Lyme disease vaccine, trading at 9.1x forward P/E despite being 55% below its ...
It's rare to get such a massive high-yielder that's also positioning itself for long-term growth. Of course, shares of Pfizer (NYSE:PFE) have faced immense challenges in the years that followed its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results